The tolerability of riluzole in the treatment of patients with amyotrophic lateral sclerosis

ISSN： 1474-0338

Source： Expert Opinion on Drug Safety, Vol.3, Iss.6, 2004-11, pp. : 525-534

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Amyotrophic lateral sclerosis, excitotoxicity and riluzole

By Obrenovitch T.P.

Trends in Pharmacological Sciences, Vol. 19, Iss. 1, 1998-01 ,pp. : 9-9

Elsevier

Access to resources Recommend Favorite

Riluzole, Neuroprotection and Amyotrophic Lateral Sclerosis

Current Medicinal Chemistry, Vol. 17, Iss. 18, 2010-06 ,pp. : 1942-1959

Bentham Science Publishers

Access to resources Recommend Favorite

Cost Effectiveness of Riluzole in Amyotrophic Lateral Sclerosis

By Messori A.

PharmacoEconomics, Vol. 16, Iss. 2, 1999-08 ,pp. : 153-163

Adis International

Access to resources Recommend Favorite

Riluzole Use During Pregnancy in a Patient with Amyotrophic Lateral Sclerosis: a Case Report

By Kawamichi Y Makino Y Matsuda Y Miyazaki K Uchiyama S Ohta H

The Journal of International Medical Research, Vol. 38, Iss. 2, 2010-03 ,pp. : 720-726

Field House Publishing

Access to resources Recommend Favorite

Single-dose Pharmacokinetics and Tolerability of Oral Delta-9- Tetrahydrocannabinol in Patients with Amyotrophic Lateral Sclerosis

Drug Metabolism Letters, Vol. 6, Iss. 2, 2012-01 ,pp. : 102-108

Bentham Science Publishers

Access to resources Recommend Favorite